Kasow, Kimberly A <br/><br/>
Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Nov 2011 
 - 169-76 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2011.07.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm<br/>Bone Marrow Transplantation<br/>Cell Survival<br/>Forkhead Transcription Factors--deficiency<br/>Genetic Diseases, X-Linked--genetics<br/>Graft Enhancement, Immunologic<br/>Graft Survival<br/>Humans<br/>Immunologic Deficiency Syndromes--genetics<br/>Infant<br/>Interleukin-2 Receptor alpha Subunit--analysis<br/>Lymphocyte Depletion<br/>Male<br/>Melphalan<br/>Point Mutation<br/>T-Lymphocyte Subsets--cytology<br/>T-Lymphocytes, Regulatory--cytology<br/>Thiotepa<br/>Thymus Gland--immunology<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Vidarabine--analogs & derivatives